US confirms six athletes failed tests for modafinil
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The United States Olympic Committee confirmed yesterday that the world 100 and 200 metres champion, Kelli White, and five other American athletes have tested positive for the banned stimulant modafinil.
White, the sprinter Chryste Gaines, the hurdlers Sandra Glover, Chris Phillips and Eric Thomas, and the hammer thrower John McEwen tested positive for the stimulant at either the US or World Athletics Championships, the USOC admitted in a statement.
McEwen also tested positive for the designer steroid tetrahydrogestrinone (THG).
The USOC also said the cyclist Adham Sbeih tested positive for erythropoietin at the US Cycling Federation Elite Track National Championships in August.
"USADA's [US Anti-Doping Agency] Anti-Doping Review Board determined that sufficient evidence of doping exists to proceed further in seven cases," the USOC said.
"All seven athletes are disputing their cases in the USADA adjudication process," the Olympic Committee added. "If a sanction is imposed, USADA will make the announcement at a later date."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments